Effect of renal function on the pharmacokinetics (PK), pharmacodynamics (PD), and safety of zoledronic acid in cancer patients with bone metastases. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Berenson, J
  • Major, Pierre
  • Miller, W
  • Schran, H
  • Ravera, C
  • Skerjanec, A
  • Waldmeier, F

publication date

  • November 16, 2001

published in